首页> 外文会议>International Conference on Genome Informatics >Selection of Causal Gene Sets From Gene Expression Profiles Using Genefis~r, New Software Based On Fnn
【24h】

Selection of Causal Gene Sets From Gene Expression Profiles Using Genefis~r, New Software Based On Fnn

机译:基于FNN的新软件选择从基因表达谱系中的因果基因组

获取原文

摘要

Microarray data were useful in disease diagnosis and prognosis. Most approaches to the computational analysis of gene expression data are functionally significant classification of genes [1, 6, 7]. Fuzzy Neural Network (FNN) is one of the advanced ANN models. FNN system can automatically select the causal gene set consisting of several genes for prediction of the disease diagnosis and prognosis and the constructed prediction models showed more than 90% accuracy from cDNA microarray [2] or oligonu-cleotide microarrays [3] for diffuse large B cell lymphoma (DLBCL) patients. In the present paper, we introduce the customized software, GeneFIS~R (Fuzzy Inference System for Gene expression analysis), which is incorporated in FNN modeling for prognostic prediction from gene expression data. The majoritarian decision using multiple noninferior models can be also provided as an optional function. Here, we analyzed here the outcome prediction of 220 DLBCL patients with high heterogeneity using GeneFIS~R.
机译:微阵列数据可用于疾病诊断和预后。大多数关于基因表达数据计算分析的方法是功能性显着的基因分类[1,6,7]。模糊神经网络(FNN)是一个先进的ANN型号之一。 FNN系统可以自动选择由几个基因组成的因果基因集,用于预测疾病诊断和预后,并且构建的预测模型从cDNA微阵列[2]或寡核苷酸微阵列[3]弥漫性大b的精度超过90%细胞淋巴瘤(DLBCL)患者。在本文中,我们介绍了定制的软件,Genefis〜R(用于基因表达分析的模糊推理系统),其掺入FNN建模中,用于来自基因表达数据的预后预测。使用多个非流入模型的主要决策也可以作为可选功能提供。在此,我们在此分析了使用Genefis〜R具有高异质性的220名DLBCL患者的结果预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号